100 related articles for article (PubMed ID: 34467223)
1. A tissue culture infectious dose-derived protocol for testing of SARS-CoV-2 neutralization of serum antibodies on adherent cells.
Hasler F; Duda A; Kündig TM; Johansen P
STAR Protoc; 2021 Dec; 2(4):100824. PubMed ID: 34467223
[TBL] [Abstract][Full Text] [Related]
2. A Novel In-Cell ELISA Assay Allows Rapid and Automated Quantification of SARS-CoV-2 to Analyze Neutralizing Antibodies and Antiviral Compounds.
Schöler L; Le-Trilling VTK; Eilbrecht M; Mennerich D; Anastasiou OE; Krawczyk A; Herrmann A; Dittmer U; Trilling M
Front Immunol; 2020; 11():573526. PubMed ID: 33162987
[TBL] [Abstract][Full Text] [Related]
3. Scalable, Micro-Neutralization Assay for Assessment of SARS-CoV-2 (COVID-19) Virus-Neutralizing Antibodies in Human Clinical Samples.
Bennett RS; Postnikova EN; Liang J; Gross R; Mazur S; Dixit S; Kocher G; Yu S; Georgia-Clark S; Gerhardt D; Cai Y; Marron L; Lukin VV; Holbrook MR
Viruses; 2021 May; 13(5):. PubMed ID: 34065987
[TBL] [Abstract][Full Text] [Related]
4. Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2.
Park JG; Oladunni FS; Chiem K; Ye C; Pipenbrink M; Moran T; Walter MR; Kobie J; Martinez-Sobrido L
J Virol Methods; 2021 Jan; 287():113995. PubMed ID: 33068703
[TBL] [Abstract][Full Text] [Related]
5. Evaluating Humoral Immunity against SARS-CoV-2: Validation of a Plaque-Reduction Neutralization Test and a Multilaboratory Comparison of Conventional and Surrogate Neutralization Assays.
Valcourt EJ; Manguiat K; Robinson A; Lin YC; Abe KT; Mubareka S; Shigayeva A; Zhong Z; Girardin RC; DuPuis A; Payne A; McDonough K; Wang Z; Gasser R; Laumaea A; Benlarbi M; Richard J; Prévost J; Anand SP; Dimitrova K; Phillipson C; McGeer A; Gingras AC; Liang C; Petric M; Sekirov I; Morshed M; Finzi A; Drebot M; Wood H
Microbiol Spectr; 2021 Dec; 9(3):e0088621. PubMed ID: 34787495
[TBL] [Abstract][Full Text] [Related]
6. Robust Neutralizing Antibody Levels Detected after Either SARS-CoV-2 Vaccination or One Year after Infection.
Glöckner S; Hornung F; Baier M; Weis S; Pletz MW; Deinhardt-Emmer S; Löffler B; The CoNAN Study Group
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696428
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of SARS-CoV-2 neutralizing antibodies using a CPE-based colorimetric live virus micro-neutralization assay in human serum samples.
Manenti A; Maggetti M; Casa E; Martinuzzi D; Torelli A; Trombetta CM; Marchi S; Montomoli E
J Med Virol; 2020 Oct; 92(10):2096-2104. PubMed ID: 32383254
[TBL] [Abstract][Full Text] [Related]
8. Rapid quantitative screening assay for SARS-CoV-2 neutralizing antibodies using HiBiT-tagged virus-like particles.
Miyakawa K; Jeremiah SS; Ohtake N; Matsunaga S; Yamaoka Y; Nishi M; Morita T; Saji R; Nishii M; Kimura H; Hasegawa H; Takeuchi I; Ryo A
J Mol Cell Biol; 2020 Nov; 12(12):987-990. PubMed ID: 32931563
[No Abstract] [Full Text] [Related]
9. A rapid real-time polymerase chain reaction-based live virus microneutralization assay for detection of neutralizing antibodies against SARS-CoV-2 in blood/serum.
Abidi SH; Imtiaz K; Kanji A; Qaiser S; Khan E; Iqbal K; Veldhoen M; Ghias K; Simas JP; Hasan Z
PLoS One; 2021; 16(12):e0259551. PubMed ID: 34890401
[TBL] [Abstract][Full Text] [Related]
10. Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples.
Mazzini L; Martinuzzi D; Hyseni I; Benincasa L; Molesti E; Casa E; Lapini G; Piu P; Trombetta CM; Marchi S; Razzano I; Manenti A; Montomoli E
J Immunol Methods; 2021 Feb; 489():112937. PubMed ID: 33253698
[TBL] [Abstract][Full Text] [Related]
11. Comparison of potency assays to assess SARS-CoV-2 neutralizing antibody capacity in COVID-19 convalescent plasma.
von Rhein C; Scholz T; Henss L; Kronstein-Wiedemann R; Schwarz T; Rodionov RN; Corman VM; Tonn T; Schnierle BS
J Virol Methods; 2021 Feb; 288():114031. PubMed ID: 33275926
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a commercially-available surrogate virus neutralization test for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
Valcourt EJ; Manguiat K; Robinson A; Chen JC; Dimitrova K; Philipson C; Lamoureux L; McLachlan E; Schiffman Z; Drebot MA; Wood H
Diagn Microbiol Infect Dis; 2021 Apr; 99(4):115294. PubMed ID: 33387896
[TBL] [Abstract][Full Text] [Related]
13. Development of a Rapid Focus Reduction Neutralization Test Assay for Measuring SARS-CoV-2 Neutralizing Antibodies.
Vanderheiden A; Edara VV; Floyd K; Kauffman RC; Mantus G; Anderson E; Rouphael N; Edupuganti S; Shi PY; Menachery VD; Wrammert J; Suthar MS
Curr Protoc Immunol; 2020 Dec; 131(1):e116. PubMed ID: 33215858
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein.
Tani H; Kimura M; Tan L; Yoshida Y; Ozawa T; Kishi H; Fukushi S; Saijo M; Sano K; Suzuki T; Kawasuji H; Ueno A; Miyajima Y; Fukui Y; Sakamaki I; Yamamoto Y; Morinaga Y
Virol J; 2021 Jan; 18(1):16. PubMed ID: 33435994
[TBL] [Abstract][Full Text] [Related]
15. Neutralization of alpha, gamma, and D614G SARS-CoV-2 variants by CoronaVac vaccine-induced antibodies.
Fernández J; Bruneau N; Fasce R; Martín HS; Balanda M; Bustos P; Ulloa S; Mora J; Ramírez E
J Med Virol; 2022 Jan; 94(1):399-403. PubMed ID: 34460119
[TBL] [Abstract][Full Text] [Related]
16. An Assessment of Serological Assays for SARS-CoV-2 as Surrogates for Authentic Virus Neutralization.
Wohlgemuth N; Whitt K; Cherry S; Kirkpatrick Roubidoux E; Lin CY; Allison KJ; Gowen A; Freiden P; Allen EK; ; Gaur AH; Estepp JH; Tang L; Mori T; Hijano DR; Hakim H; McGargill MA; Krammer F; Whitt MA; Wolf J; Thomas PG; Schultz-Cherry S
Microbiol Spectr; 2021 Oct; 9(2):e0105921. PubMed ID: 34704832
[TBL] [Abstract][Full Text] [Related]
17. Recent Developments in SARS-CoV-2 Neutralizing Antibody Detection Methods.
Banga Ndzouboukou JL; Zhang YD; Fan XL
Curr Med Sci; 2021 Dec; 41(6):1052-1064. PubMed ID: 34935114
[TBL] [Abstract][Full Text] [Related]
18. BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants.
Liu J; Liu Y; Xia H; Zou J; Weaver SC; Swanson KA; Cai H; Cutler M; Cooper D; Muik A; Jansen KU; Sahin U; Xie X; Dormitzer PR; Shi PY
Nature; 2021 Aug; 596(7871):273-275. PubMed ID: 34111888
[TBL] [Abstract][Full Text] [Related]
19. Robust neutralizing antibodies to SARS-CoV-2 infection persist for months.
Wajnberg A; Amanat F; Firpo A; Altman DR; Bailey MJ; Mansour M; McMahon M; Meade P; Mendu DR; Muellers K; Stadlbauer D; Stone K; Strohmeier S; Simon V; Aberg J; Reich DL; Krammer F; Cordon-Cardo C
Science; 2020 Dec; 370(6521):1227-1230. PubMed ID: 33115920
[TBL] [Abstract][Full Text] [Related]
20. Quantification of SARS-CoV-2 neutralizing antibody by wild-type plaque reduction neutralization, microneutralization and pseudotyped virus neutralization assays.
Bewley KR; Coombes NS; Gagnon L; McInroy L; Baker N; Shaik I; St-Jean JR; St-Amant N; Buttigieg KR; Humphries HE; Godwin KJ; Brunt E; Allen L; Leung S; Brown PJ; Penn EJ; Thomas K; Kulnis G; Hallis B; Carroll M; Funnell S; Charlton S
Nat Protoc; 2021 Jun; 16(6):3114-3140. PubMed ID: 33893470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
